rxlist.com (Byetta ) rxlist.com (Byduron ) extended release formulation Keywords Liraglutide Trade Names: Victoza & generic Pharmacology: GLP-1 analog mechanism of action is the same as exenatide Indications: an adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease Pharmacokinetics: once-daily injection Side Effects: Most common : nausea, diarrhea, vomiting (similar to exenatide) Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Another surprising link had to do with aspiration pneumonia, or the risk that someone might vomit and some of that undigested food might get into their lungs and cause an infection
Once commercially available (expected late 2026-2027), brand-name retatrutide pricing will likely mirror or exceed tirzepatide pricing, given Eli Lilly manufactures both compounds and the market dynamics of premium obesity medications
It is a good fit for individuals who prefer self-guided digital tools, while Found appeals to those who want more personalized, human-centered coaching and accountability
Retatrutide is only being studied as a once-weekly injection
This is simply because Ozempic drug trials focused on how it impacted blood sugar (like metformin does), while Wegovy drug trials focused on how it impacted weight
